|
Market Cap | 24.47B | EPS (ttm) | 8.42 |
P/E | 13.01 | EPS this Y | 16.28% |
Forward P/E | 12.48 | EPS next Y | -0.51% |
PEG | 18.58 | EPS past 5Y | 1.31% |
P/S | 3.67 | EPS next 5Y | 0.70% |
P/B | 2.50 | EPS Q/Q | 36.37% |
Dividend | 4.51% | Sales Q/Q | 13.83% |
Insider Own | 2.24% | Inst Own | 75.82% |
Insider Trans | -1.80% | Inst Trans | 1.56% |
Short Float | 4.92% | Earnings | Apr 26/b |
Analyst Recom | 3.60 | Target Price | 113.50 |
Avg Volume | 1.44M | 52W Range | 87.43 - 132.76 |
|
|
|
T. Rowe Price Group, Inc. engages in the provision of investment management services. The company was founded by Thomas Rowe Price Jr. in 1937 and is headquartered in Baltimore, MD. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
MacLellan Robert F. | Director | Apr 29 '24 | Option Exercise | 78.59 | 4,370 | 343,437 | 37,678 | Apr 30 10:20 AM | MacLellan Robert F. | Director | Apr 29 '24 | Sale | 113.08 | 3,043 | 344,102 | 34,635 | Apr 30 10:20 AM | HRABOWSKI FREEMAN A III | Director | Mar 08 '24 | Option Exercise | 77.64 | 8,740 | 678,560 | 29,813 | Mar 11 02:53 PM | HRABOWSKI FREEMAN A III | Director | Mar 08 '24 | Sale | 118.32 | 8,740 | 1,034,147 | 21,073 | Mar 11 02:53 PM | Hiebler Jessica M | Principal Accounting Officer | Feb 09 '24 | Option Exercise | 77.18 | 1,138 | 87,836 | 15,251 | Feb 12 11:32 AM |
|
|
|
|
Market Cap | 4.36B | EPS (ttm) | 14.83 |
P/E | 6.61 | EPS this Y | 3.33% |
Forward P/E | 7.95 | EPS next Y | 15.01% |
PEG | 0.94 | EPS past 5Y | - |
P/S | 0.61 | EPS next 5Y | 7.00% |
P/B | 2.00 | EPS Q/Q | 141.35% |
Dividend | 1.20% | Sales Q/Q | -6.32% |
Insider Own | 4.44% | Inst Own | 106.71% |
Insider Trans | -14.78% | Inst Trans | -3.73% |
Short Float | 9.47% | Earnings | Mar 20/b |
Analyst Recom | 2.12 | Target Price | 122.30 |
Avg Volume | 741.74K | 52W Range | 57.10 - 109.17 |
|
|
|
Signet Jewelers Ltd. engages in the retail of diamond jewelry. It operates through the following business segments: North America, International, and Others. The North America segment operates jewelry stores in malls, mall-based kiosks, and off-mall locations throughout the U.S. and Canada. The International segment sells primarily in the UK and Ireland under the H. Samuel and Ernest Jones banners. The Other segment consists of activities related to purchasing and conversion of rough diamonds to polished stones and unallocated corporate administrative functions. The company was founded in 1949 and is headquartered in Hamilton, Bermuda. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Ciccolini Vincent | Chief Accounting Officer | Apr 26 '24 | Sale | 101.64 | 4,000 | 406,557 | 46,076 | Apr 30 07:23 AM | Stitzer H. Todd | Director | Apr 22 '24 | Sale | 100.09 | 10,000 | 1,000,883 | 41,678 | Apr 23 07:04 PM | Stitzer H. Todd | Director | Apr 10 '24 | Sale | 100.07 | 5,000 | 500,362 | 51,678 | Apr 15 05:01 PM | Stitzer H. Todd | Director | Apr 09 '24 | Sale | 102.41 | 5,000 | 512,057 | 56,678 | Apr 15 05:01 PM | Drosos Virginia | Chief Executive Officer | Apr 01 '24 | Sale | 99.75 | 45,000 | 4,488,580 | 778,820 | Apr 03 04:06 PM |
|
|
|
|
Market Cap | 1.29B | EPS (ttm) | 2.30 |
P/E | 13.81 | EPS this Y | 26.52% |
Forward P/E | 8.71 | EPS next Y | 25.43% |
PEG | - | EPS past 5Y | 208.72% |
P/S | 1.84 | EPS next 5Y | - |
P/B | 4.46 | EPS Q/Q | 151.39% |
Dividend | - | Sales Q/Q | 94.85% |
Insider Own | 58.84% | Inst Own | 16.15% |
Insider Trans | -3.90% | Inst Trans | 375.82% |
Short Float | 14.93% | Earnings | Mar 15/b |
Analyst Recom | 1.00 | Target Price | 40.50 |
Avg Volume | 2.95M | 52W Range | 4.97 - 45.18 |
|
|
|
GigaCloud Technology, Inc. specializes in global end-to-end business-to-business (B2B) electronic commerce (e-commerce) for large parcel merchandise. The firm's B2B ecommerce platform, which it refers to as the GigaCloud Marketplace, integrates everything from product discovery, payments, and messaging portals, leveraging channel diversification for suppliers, while resellers gain access to thousands of products backed by a complete logistics package. Its global marketplace seamlessly connects manufacturers, primarily in Asia, with resellers, primarily in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. The firm offers a comprehensive solution that transports products from the manufacturer's warehouse to the end customer's doorstep, all in one place. The company was founded by Lei Wu on August 29, 2006 and is headquartered in El Monte, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Wu Lei | Chief Executive Officer | Apr 26 '24 | Sale | 35.89 | 44,000 | 1,579,291 | 797,816 | Apr 29 09:49 PM | Wu Lei | Chief Executive Officer | Apr 25 '24 | Sale | 36.12 | 44,000 | 1,589,200 | 841,816 | Apr 29 09:49 PM | Wu Lei | Chief Executive Officer | Apr 24 '24 | Sale | 36.54 | 44,000 | 1,607,722 | 885,816 | Apr 26 09:23 PM | Wu Lei | Chief Executive Officer | Apr 23 '24 | Sale | 36.36 | 44,000 | 1,599,940 | 929,816 | Apr 24 09:28 PM | Wu Lei | Chief Executive Officer | Apr 22 '24 | Sale | 35.98 | 44,000 | 1,583,273 | 973,816 | Apr 24 09:28 PM |
|
|
| |
|
Market Cap | 862.86M | EPS (ttm) | -2.79 |
P/E | - | EPS this Y | -4.08% |
Forward P/E | - | EPS next Y | 3.13% |
PEG | - | EPS past 5Y | -38.74% |
P/S | 33.77 | EPS next 5Y | - |
P/B | 1.11 | EPS Q/Q | -19.95% |
Dividend | - | Sales Q/Q | -100.00% |
Insider Own | 29.71% | Inst Own | 71.10% |
Insider Trans | -0.07% | Inst Trans | 1.50% |
Short Float | 11.49% | Earnings | May 02/a |
Analyst Recom | 1.18 | Target Price | 24.30 |
Avg Volume | 1.21M | 52W Range | 5.70 - 13.32 |
|
|
|
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Bergstrom Donald A | President, R&D | Apr 29 '24 | Sale | 6.38 | 2,686 | 17,137 | 527,427 | Apr 29 08:30 PM | Catinazzo Thomas | Chief Financial Officer | Apr 29 '24 | Sale | 6.38 | 1,695 | 10,814 | 339,803 | Apr 29 08:31 PM | Adams Brian | Chief Legal Officer | Apr 29 '24 | Sale | 6.38 | 1,623 | 10,355 | 325,767 | Apr 29 08:33 PM | Rahmer Peter | See remarks | Apr 29 '24 | Sale | 6.38 | 1,345 | 8,581 | 513,334 | Apr 29 08:36 PM | Bergstrom Donald A | President, R&D | Mar 27 '24 | Sale | 7.70 | 765 | 5,890 | 530,113 | Mar 29 04:15 PM |
|
|
|
|
Market Cap | 1.21B | EPS (ttm) | 1.48 |
P/E | 10.46 | EPS this Y | -49.27% |
Forward P/E | 12.35 | EPS next Y | 28.29% |
PEG | 0.37 | EPS past 5Y | - |
P/S | 0.84 | EPS next 5Y | 28.30% |
P/B | 1.39 | EPS Q/Q | -69.63% |
Dividend | - | Sales Q/Q | -26.30% |
Insider Own | 3.51% | Inst Own | 88.56% |
Insider Trans | -3.83% | Inst Trans | 2.97% |
Short Float | 8.49% | Earnings | Apr 26/b |
Analyst Recom | 3.00 | Target Price | 14.50 |
Avg Volume | 1.13M | 52W Range | 10.09 - 16.03 |
|
|
|
U.S. Silica Holdings, Inc. engages in the provision of commercial silica products. It operates through the following segments: Oil and Gas Proppants, and Industrial and Specialty Products. The Oil and Gas Proppants segment focuses on delivering fracturing sand, which is pumped down oil and natural gas wells to prop open rock fissures and increase the flow rate of natural gas and oil from the wells. The Industrial and Specialty products segment consists of products and materials used in various industries, including container glass, fiberglass, specialty glass, flat glass, building products, fillers and extenders, foundry products, chemicals, recreation products and filtration products. The company was founded on November 14, 2008 and is headquartered in Katy, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Carusona Zach | EVP & President, ISP | Apr 26 '24 | Sale | 15.55 | 42,605 | 662,508 | 160,929 | Apr 29 08:11 PM | USSERY JAMES DEREK | EVP & President, Oil and Gas | Apr 03 '24 | Sale | 14.00 | 46,433 | 650,062 | 174,772 | Apr 04 04:09 PM | Russell Stacy | EVP General Counsel | Mar 11 '24 | Sale | 12.00 | 20,000 | 240,000 | 186,752 | Mar 13 04:07 PM | Shinn Bryan Adair | CEO | Sep 12 '23 | Sale | 14.06 | 41,501 | 583,338 | 1,419,183 | Sep 13 04:33 PM |
|
|
| |
|
Market Cap | 90.20B | EPS (ttm) | 3.04 |
P/E | 38.41 | EPS this Y | 18.14% |
Forward P/E | 25.05 | EPS next Y | 25.55% |
PEG | - | EPS past 5Y | 9.46% |
P/S | 9.30 | EPS next 5Y | - |
P/B | 11.96 | EPS Q/Q | -9.50% |
Dividend | 2.80% | Sales Q/Q | -6.95% |
Insider Own | 88.99% | Inst Own | 8.13% |
Insider Trans | -0.00% | Inst Trans | -2.47% |
Short Float | 6.89% | Earnings | Apr 25/b |
Analyst Recom | 3.68 | Target Price | 80.34 |
Avg Volume | 1.22M | 52W Range | 64.66 - 121.00 |
|
|
|
Southern Copper Corp. engages in the development, production, and exploration of copper, molybdenum, zinc, and silver. It operates through the following segments: Peruvian Operations, Mexican Open-Pit Operations, and Mexican Underground Mining Operations. The Peruvian Operations segment focuses on the Toquepala and Cuajone mine complexes and the smelting and refining plants, industrial railroad, and port facilities that service both mines. The Mexican Open-Pit Operations segment comprises the La Caridad and Buenavista mine complexes, the smelting, and refining plants and support facilities, which service both mines. The Mexican Underground Mining Operations segment is involved in the operation of five underground mines, a coal mine, and several industrial processing facilities. The company was founded on December 12, 1952 and is headquartered in Phoenix, AZ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
PALOMINO BONILLA LUIS MIGUEL | Director | Apr 29 '24 | Sale | 118.50 | 300 | 35,550 | 4,614 | Apr 29 07:48 PM | PALOMINO BONILLA LUIS MIGUEL | Director | Apr 03 '24 | Sale | 110.20 | 100 | 11,020 | 4,914 | Apr 04 01:04 PM | PALOMINO BONILLA LUIS MIGUEL | Director | Mar 13 '24 | Sale | 87.10 | 100 | 8,710 | 5,014 | Mar 14 08:33 PM | PALOMINO BONILLA LUIS MIGUEL | Director | Mar 07 '24 | Sale | 85.00 | 197 | 16,745 | 5,114 | Mar 08 05:03 PM | PALOMINO BONILLA LUIS MIGUEL | Director | Mar 04 '24 | Sale | 81.50 | 100 | 8,150 | 5,311 | Mar 05 01:05 PM |
|
|
|
|
Market Cap | 300.41M | EPS (ttm) | 0.75 |
P/E | 27.19 | EPS this Y | 42.00% |
Forward P/E | 16.76 | EPS next Y | 14.55% |
PEG | 2.72 | EPS past 5Y | - |
P/S | 1.88 | EPS next 5Y | 10.00% |
P/B | 4.97 | EPS Q/Q | 468.70% |
Dividend | - | Sales Q/Q | 17.45% |
Insider Own | 69.47% | Inst Own | 15.91% |
Insider Trans | -2.66% | Inst Trans | -4.28% |
Short Float | 3.65% | Earnings | Mar 20/b |
Analyst Recom | 2.00 | Target Price | 22.25 |
Avg Volume | 113.70K | 52W Range | 5.61 - 25.01 |
|
|
|
Lifeway Foods, Inc. engages in the manufacture of probiotic and nutritious foods. Its products include kefir, organic kefir, plantiful, probugs, frozen kefir, cups and skyr, cheese, and supplements. The company distributes its products primarily through its direct sales force, brokers, and distributors. Lifeway Foods was founded by Michael Smolyansky and Ludmila Smolyansky in February 1986 and is headquartered in Morton Grove, IL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
SMOLYANSKY LUDMILA | Member of 10% owner group | Apr 26 '24 | Sale | 23.02 | 20,000 | 460,300 | 1,234,753 | Apr 29 07:21 PM | SMOLYANSKY LUDMILA | Member of 10% owner group | Apr 25 '24 | Sale | 21.56 | 3,620 | 78,047 | 1,254,753 | Apr 25 08:57 PM | SMOLYANSKY LUDMILA | Member of 10% owner group | Apr 24 '24 | Sale | 21.64 | 10,000 | 216,400 | 1,258,373 | Apr 25 08:57 PM | SMOLYANSKY LUDMILA | Member of 10% owner group | Apr 23 '24 | Sale | 20.33 | 21,968 | 446,609 | 1,268,373 | Apr 25 08:57 PM | SMOLYANSKY LUDMILA | Member of 10% owner group | Apr 17 '24 | Sale | 20.04 | 10,000 | 200,400 | 1,290,341 | Apr 17 07:58 PM |
|
|
| |
|
Market Cap | 814.03M | EPS (ttm) | -2.18 |
P/E | - | EPS this Y | -14.08% |
Forward P/E | - | EPS next Y | -23.60% |
PEG | - | EPS past 5Y | 5.16% |
P/S | - | EPS next 5Y | - |
P/B | 2.92 | EPS Q/Q | -109.62% |
Dividend | - | Sales Q/Q | - |
Insider Own | 45.90% | Inst Own | 45.48% |
Insider Trans | -7.56% | Inst Trans | -9.24% |
Short Float | 18.33% | Earnings | Mar 14/a |
Analyst Recom | 1.00 | Target Price | 34.33 |
Avg Volume | 266.21K | 52W Range | 9.80 - 26.00 |
|
|
|
Enliven Therapeutics, Inc. operates as a clinical stage precision oncology company. It is focused on the discovery and development of next-generation small molecule kinase inhibitors and advancing Enliven's pipeline of precision oncology product candidates. The company was founded by Sam S. Kintz, Joe P. Lyssikatos, and Anish Patel in June 2019 and is headquartered in Boulder, CO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Kintz Samuel | PRESIDENT AND CEO | Apr 25 '24 | Option Exercise | 1.12 | 12,000 | 13,440 | 12,000 | Apr 29 06:50 PM | Kintz Samuel | PRESIDENT AND CEO | Apr 25 '24 | Sale | 16.89 | 12,000 | 202,700 | 0 | Apr 29 06:50 PM | Heyman Richard A. | Director | Apr 15 '24 | Sale | 19.99 | 1,270 | 25,383 | 137,155 | Apr 15 07:03 PM | Ballal Rahul D. | Director | Apr 11 '24 | Option Exercise | 13.21 | 53,400 | 705,266 | 75,741 | Apr 12 06:23 PM | Kintz Samuel | PRESIDENT AND CEO | Apr 11 '24 | Option Exercise | 1.12 | 47,709 | 53,434 | 47,709 | Apr 15 07:05 PM |
|
|
|
|
Market Cap | 1.86B | EPS (ttm) | -1.55 |
P/E | - | EPS this Y | -9.14% |
Forward P/E | - | EPS next Y | -7.82% |
PEG | - | EPS past 5Y | -43.41% |
P/S | 41.66 | EPS next 5Y | 12.00% |
P/B | 3.95 | EPS Q/Q | -28.81% |
Dividend | - | Sales Q/Q | -20.36% |
Insider Own | 31.78% | Inst Own | 75.35% |
Insider Trans | -1.46% | Inst Trans | 4.55% |
Short Float | 23.89% | Earnings | Feb 27/a |
Analyst Recom | 2.43 | Target Price | 13.00 |
Avg Volume | 6.35M | 52W Range | 4.54 - 16.75 |
|
|
|
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Marriott Tina | President and COO | Apr 25 '24 | Option Exercise | 1.06 | 3,000 | 3,180 | 546,231 | Apr 29 06:41 PM | Marriott Tina | President and COO | Apr 25 '24 | Sale | 7.67 | 3,000 | 23,020 | 543,231 | Apr 29 06:41 PM | Secora Michael | Chief Financial Officer | Apr 17 '24 | Option Exercise | 2.22 | 37,500 | 83,250 | 1,254,179 | Apr 18 05:12 PM | Secora Michael | Chief Financial Officer | Apr 17 '24 | Sale | 7.58 | 23,124 | 175,349 | 1,231,055 | Apr 18 05:12 PM | Secora Michael | Chief Financial Officer | Apr 16 '24 | Option Exercise | 2.22 | 37,500 | 83,250 | 1,241,679 | Apr 18 05:12 PM |
|
|
|
|
Market Cap | 19.77B | EPS (ttm) | 2.76 |
P/E | 20.99 | EPS this Y | 12.41% |
Forward P/E | 15.18 | EPS next Y | 6.61% |
PEG | 2.80 | EPS past 5Y | -6.41% |
P/S | 1.30 | EPS next 5Y | 7.49% |
P/B | 6.21 | EPS Q/Q | 127.39% |
Dividend | 3.96% | Sales Q/Q | -17.19% |
Insider Own | 16.10% | Inst Own | 71.81% |
Insider Trans | -3.29% | Inst Trans | -1.00% |
Short Float | 3.97% | Earnings | May 02/b |
Analyst Recom | 2.76 | Target Price | 59.24 |
Avg Volume | 3.22M | 52W Range | 47.62 - 67.84 |
|
|
|
Kellanova engages in the manufacturing, marketing, and distribution of ready-to-eat cereal and convenience foods. It operates through the following segments: North America, Europe, Latin America, and Asia Middle East Africa. The North America segment includes the U.S. businesses and Canada. The Europe segment consists of European countries. The Latin America segment focuses on Central and South America, and Mexico. The Asia Middle East Africa segment is involved in Africa, Middle East, Australia, and Other Asian and Pacific markets. The company was founded by Will Keith Kellogg in 1906 and is headquartered in Chicago, IL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
KELLOGG W K FOUNDATION TRUST | 10% Owner | Apr 29 '24 | Sale | 58.00 | 77,800 | 4,512,618 | 51,842,238 | Apr 29 05:59 PM | KELLOGG W K FOUNDATION TRUST | 10% Owner | Apr 22 '24 | Sale | 57.76 | 77,800 | 4,493,386 | 51,920,038 | Apr 22 05:44 PM | KELLOGG W K FOUNDATION TRUST | 10% Owner | Apr 15 '24 | Sale | 55.35 | 77,800 | 4,306,051 | 51,997,838 | Apr 15 05:10 PM | KELLOGG W K FOUNDATION TRUST | 10% Owner | Apr 08 '24 | Sale | 57.46 | 77,800 | 4,470,162 | 52,075,638 | Apr 10 10:06 AM | KELLOGG W K FOUNDATION TRUST | 10% Owner | Mar 28 '24 | Sale | 57.34 | 77,800 | 4,461,029 | 52,153,438 | Mar 28 06:33 PM |
|
|
|